Literature DB >> 15930707

[Bone quality and biochemical markers].

Kentaro Kurasawa1.   

Abstract

Osteoporosis is defined as a skeletal disorder characterized by compromised bone strength predisposing a person to an increased risk of fracture. Bone strength primarily reflects the integration of bone density and bone quality. Bone density is expressed as grams of mineral per area or volume, and in any given individual is determined by peak bone mass and amount of bone loss. Bone quality refers to architecture, turnover, damage accumulation (eg, microfractures) and mineralization. However, there are no other methods to evaluate bone quality than biochemical markers at present.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930707     DOI: CliCa0506959964

Source DB:  PubMed          Journal:  Clin Calcium        ISSN: 0917-5857


  3 in total

1.  Dietary pseudopurpurin effects on bone mineral density and bone geometry architecture in rats.

Authors:  Chen-Chen Wu; Xiao-Bing Li; Tie-Suo Han; Peng Li; Guo-Wen Liu; Wei-Zhong Wang; Zhe Wang
Journal:  Int J Mol Sci       Date:  2012-03-13       Impact factor: 6.208

2.  Lycopene effects on serum mineral elements and bone strength in rats.

Authors:  Haidong Liang; Fang Yu; Zhihong Tong; Weifeng Zeng
Journal:  Molecules       Date:  2012-06-11       Impact factor: 4.411

3.  A polysaccharide from the dried rhizome of Drynaria fortunei (Kunze) J. Sm. prevents ovariectomized (OVX)-induced osteoporosis in rats.

Authors:  Xin Sun; Bo Wei; Zhiheng Peng; Xiaru Chen; Qinglong Fu; Chaojun Wang; Jinchang Zhen; Jiecong Sun
Journal:  J Cell Mol Med       Date:  2020-02-17       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.